NZ527200A - Stable norastemizole formulations including a super disintegrant - Google Patents
Stable norastemizole formulations including a super disintegrantInfo
- Publication number
- NZ527200A NZ527200A NZ52720098A NZ52720098A NZ527200A NZ 527200 A NZ527200 A NZ 527200A NZ 52720098 A NZ52720098 A NZ 52720098A NZ 52720098 A NZ52720098 A NZ 52720098A NZ 527200 A NZ527200 A NZ 527200A
- Authority
- NZ
- New Zealand
- Prior art keywords
- stable
- formulations including
- super disintegrant
- norastemizole
- norastemizole formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82447797A | 1997-03-26 | 1997-03-26 | |
| US85178697A | 1997-05-06 | 1997-05-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ527200A true NZ527200A (en) | 2004-12-24 |
Family
ID=27124816
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ517472A NZ517472A (en) | 1997-03-26 | 1998-03-25 | Lactose free norastemizole formulations with improved stability |
| NZ527201A NZ527201A (en) | 1997-03-26 | 1998-03-25 | Stable norastemizole formulations comprising coated norastemizole particles |
| NZ52720098A NZ527200A (en) | 1997-03-26 | 1998-03-25 | Stable norastemizole formulations including a super disintegrant |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ517472A NZ517472A (en) | 1997-03-26 | 1998-03-25 | Lactose free norastemizole formulations with improved stability |
| NZ527201A NZ527201A (en) | 1997-03-26 | 1998-03-25 | Stable norastemizole formulations comprising coated norastemizole particles |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1035869A1 (xx) |
| JP (1) | JP2002512614A (xx) |
| KR (1) | KR20010005746A (xx) |
| CN (1) | CN1257431A (xx) |
| AR (1) | AR012187A1 (xx) |
| BR (1) | BR9808428A (xx) |
| CA (1) | CA2284705A1 (xx) |
| HU (1) | HUP0001823A3 (xx) |
| NO (1) | NO994655L (xx) |
| NZ (3) | NZ517472A (xx) |
| RU (1) | RU2214245C2 (xx) |
| WO (1) | WO1998042379A2 (xx) |
| ZA (1) | ZA982562B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20002567A3 (cs) * | 2000-07-11 | 2001-12-12 | Léčiva, A.S. | Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby |
| EP2201982A1 (en) * | 2008-12-24 | 2010-06-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Histamine H4 receptor antagonists for the treatment of vestibular disorders |
| EA201270309A1 (ru) * | 2009-08-24 | 2012-07-30 | Абды Ибрахым Иладж Санайи Ве Тыджарет Аноным Сыркеты | Таблетки отилония, полученные прямым прессованием |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2052544T3 (es) * | 1986-02-03 | 1994-07-16 | Janssen Pharmaceutica Nv | Composiciones anti-histaminicas que contienen n-heterociclil-4-piperidinaminas. |
| DE4037426A1 (de) * | 1990-11-24 | 1992-05-27 | Kali Chemie Pharma Gmbh | Piperidinoalkylbenzoxazin- und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE69333387T2 (de) * | 1992-09-03 | 2004-12-09 | Sepracor Inc., Marlborough | Pharmazeutische Zusammensetzungen enthaltend Norastemizol. |
| JPH11513991A (ja) * | 1995-11-17 | 1999-11-30 | ヘキスト・マリオン・ルセル・インコーポレイテツド | アレルギー性疾患の治療に有用な置換４−（１ｈ−ベンズイミダゾル−２−イル−アミノ）ピペリジン |
| AU722040B2 (en) * | 1996-08-16 | 2000-07-20 | Schering Corporation | Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
-
1998
- 1998-03-25 NZ NZ517472A patent/NZ517472A/en unknown
- 1998-03-25 KR KR1019997008817A patent/KR20010005746A/ko not_active Application Discontinuation
- 1998-03-25 HU HU0001823A patent/HUP0001823A3/hu unknown
- 1998-03-25 NZ NZ527201A patent/NZ527201A/xx unknown
- 1998-03-25 JP JP54589398A patent/JP2002512614A/ja active Pending
- 1998-03-25 CA CA002284705A patent/CA2284705A1/en not_active Abandoned
- 1998-03-25 EP EP98914283A patent/EP1035869A1/en not_active Withdrawn
- 1998-03-25 NZ NZ52720098A patent/NZ527200A/xx unknown
- 1998-03-25 BR BR9808428-3A patent/BR9808428A/pt not_active IP Right Cessation
- 1998-03-25 RU RU99122607/14A patent/RU2214245C2/ru not_active IP Right Cessation
- 1998-03-25 CN CN98805457A patent/CN1257431A/zh active Pending
- 1998-03-25 WO PCT/US1998/005701 patent/WO1998042379A2/en not_active Application Discontinuation
- 1998-03-26 ZA ZA982562A patent/ZA982562B/xx unknown
- 1998-03-26 AR ARP980101398A patent/AR012187A1/es unknown
-
1999
- 1999-09-24 NO NO994655A patent/NO994655L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA982562B (en) | 1998-10-01 |
| RU2214245C2 (ru) | 2003-10-20 |
| NZ517472A (en) | 2003-08-29 |
| AU6868098A (en) | 1998-10-20 |
| AU735257B2 (en) | 2001-07-05 |
| HUP0001823A2 (hu) | 2001-04-28 |
| WO1998042379A2 (en) | 1998-10-01 |
| NO994655D0 (no) | 1999-09-24 |
| CA2284705A1 (en) | 1998-10-01 |
| WO1998042379A3 (en) | 2001-03-01 |
| JP2002512614A (ja) | 2002-04-23 |
| HUP0001823A3 (en) | 2002-04-29 |
| NO994655L (no) | 1999-11-15 |
| NZ527201A (en) | 2004-12-24 |
| AR012187A1 (es) | 2000-09-27 |
| BR9808428A (pt) | 2000-05-23 |
| KR20010005746A (ko) | 2001-01-15 |
| EP1035869A1 (en) | 2000-09-20 |
| CN1257431A (zh) | 2000-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1030747A1 (en) | Stable insulin formulations | |
| GB9715751D0 (en) | Formulations | |
| HUP0104573A3 (en) | Agrochemical formulations | |
| EP1049486A4 (en) | GLP-1 FORMULATIONS | |
| GB9713149D0 (en) | Pharmaceutical formulations | |
| GB9718139D0 (en) | Agrochemical Formulation | |
| PL343021A1 (en) | Formulations | |
| GB2323531B (en) | Therapeutic formulations | |
| ZA9811461B (en) | New formulation | |
| ZA985669B (en) | New formulation | |
| SI0884053T1 (en) | Stable insulin formulations | |
| HUP0004665A3 (en) | Anaesthetic formulation | |
| IL127655A0 (en) | Pesticidal tablet formulations | |
| ZA9810710B (en) | Sustained release formulations comprising alpha-glucosidase-inhibitors | |
| AU134029S (en) | Tillage point | |
| NZ527200A (en) | Stable norastemizole formulations including a super disintegrant | |
| AU134028S (en) | Tillage point | |
| ZA988299B (en) | Agrochemical compositions | |
| GB9815001D0 (en) | Formulations | |
| GB9815002D0 (en) | Formulations | |
| IL132780A0 (en) | A microbiocidal formulation | |
| MX9803654A (en) | Detergent formulations | |
| GB9703099D0 (en) | Formulations | |
| GB9703101D0 (en) | Formulations | |
| GB9704521D0 (en) | Formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed |